Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Adenocarcinoma Of Esophagus 2 Melanoma 1 Laryngeal Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Carcinoma, Non-Small-Cell Lung 1 Barrett Esophagus 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Oxaliplatin 26 Gemcitabine 22 Fluorouracil 17 Capecitabine 16 Leucovorin 15 pembrolizumab 14 Docetaxel 14 Cisplatin 13 Bevacizumab 12 Radiotherapy 8 Paclitaxel 8 Irinotecan 8 Trastuzumab 7 Pemetrexed 6 Carboplatin 6 130-nm albumin-bound paclitaxel 6 durvalumab 5 cemiplimab 5 Erlotinib Hydrochloride 5 Sunitinib 4 Ramucirumab 4 Metformin 4 Gefitinib 4 trastuzumab deruxtecan 3 tislelizumab 3 cabozantinib 3 atezolizumab 3 Taxes 3 Sorafenib 3 Panitumumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenocarcinoma × Endoscopy × Clear all

NCT04864067 2026-05-08

NOAHS-ARC

Servicio de Salud Metropolitano Sur Oriente

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡